Melville, New York-based Henry Schein, Inc. (HSIC) provides healthcare products and services to office-based dental and medical practitioners, as well as alternative sites of care worldwide. With a market capitalization of $8.6 billion, the company operates through four segments: Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology.
HSIC is all geared up to report its Q2 2025 results on Tuesday, August 5. Before this event, analysts project that the company will report an adjusted EPS of $1.19, down 3.3% from $1.23 in the year-ago quarter. The company has surpassed or matched Wall Street's bottom-line estimates in each of the last four quarters, which is impressive.
For fiscal 2025, analysts expect HSIC to report an adjusted EPS of $4.86, representing a 2.5% year-over-year increase from $4.74 in fiscal 2024. Moreover, in fiscal 2026, the company’s adjusted EPS is expected to increase 8.6% year-over-year to $5.28.
HSIC stock has grown 7.3% over the past 52 weeks, lagging behind the S&P 500 Index's ($SPX) 10.9% gain but outperforming the Health Care Select Sector SPDR Fund’s (XLV) 10.3% decline over the same time frame.
HSIC stock rose 2% following the release of its Q1 2025 results on May 5. The company’s net sales declined marginally year-over-year to $3.2 billion, missing the consensus estimate. Meanwhile, its adjusted EPS grew 4.5% from the prior-year quarter to $1.15, surpassing analysts’ estimate by 3.6%.
Analysts are moderately optimistic about HISC’s stock, with an overall “Moderate Buy” rating. Among 14 analysts covering the stock, five recommend “Strong Buy,” eight advise “Hold,” and one suggests “Strong Sell.” The mean price target of $77 indicates a 9% potential upside from HSIC’s current price levels.
On the date of publication, Kritika Sarmah did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Barchart.com
